A citation-based method for searching scientific literature

E P Slater, P Langer, E Niemczyk, K Strauch, J Butler, N Habbe, J P Neoptolemos, W Greenhalf, D K Bartsch. Clin Genet 2010
Times Cited: 164







List of co-cited articles
1237 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
528
70

ATM mutations in patients with hereditary pancreatic cancer.
Nicholas J Roberts, Yuchen Jiao, Jun Yu, Levy Kopelovich, Gloria M Petersen, Melissa L Bondy, Steven Gallinger, Ann G Schwartz, Sapna Syngal, Michele L Cote,[...]. Cancer Discov 2012
292
36

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
Alison P Klein, Kieran A Brune, Gloria M Petersen, Michael Goggins, Anne C Tersmette, G Johan A Offerhaus, Constance Griffin, John L Cameron, Charles J Yeo, Scott Kern,[...]. Cancer Res 2004
395
34

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Kathleen M Murphy, Kieran A Brune, Constance Griffin, Jennifer E Sollenberger, Gloria M Petersen, Ravi Bansal, Ralph H Hruban, Scott E Kern. Cancer Res 2002
311
31

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013
425
30


BRCA2 germline mutations in familial pancreatic carcinoma.
Stephan A Hahn, Bill Greenhalf, Ian Ellis, Mercedes Sina-Frey, Harald Rieder, Birgit Korte, Berthold Gerdes, Ralf Kress, Andreas Ziegler, John A Raeburn,[...]. J Natl Cancer Inst 2003
324
28

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
653
28

Risk of pancreatic cancer in families with Lynch syndrome.
Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, Fei Wang, Jennifer Sparr, Victoria M Raymond, Prathap Bandipalliam, Elena M Stoffel, Stephen B Gruber, Sapna Syngal. JAMA 2009
285
27

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.
A B Lowenfels, P Maisonneuve, E P DiMagno, Y Elitsur, L K Gates, J Perrault, D C Whitcomb. J Natl Cancer Inst 1997
661
25

Very high risk of cancer in familial Peutz-Jeghers syndrome.
F M Giardiello, J D Brensinger, A C Tersmette, S N Goodman, G M Petersen, S V Booker, M Cruz-Correa, J A Offerhaus. Gastroenterology 2000
791
25

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
480
25

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer.
Marc D Tischkowitz, Nelly Sabbaghian, Nancy Hamel, Ayelet Borgida, Chaim Rosner, Nassim Taherian, Archana Srivastava, Spring Holter, Heidi Rothenmund, Parviz Ghadirian,[...]. Gastroenterology 2009
99
24

The prevalence of BRCA2 mutations in familial pancreatic cancer.
Fergus J Couch, Michele R Johnson, Kari G Rabe, Kieran Brune, Mariza de Andrade, Michael Goggins, Heidi Rothenmund, Steven Gallinger, Alison Klein, Gloria M Petersen,[...]. Cancer Epidemiol Biomarkers Prev 2007
188
23

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
714
23

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Silvia Casadei, Barbara M Norquist, Tom Walsh, Sunday Stray, Jessica B Mandell, Ming K Lee, John A Stamatoyannopoulos, Mary-Claire King. Cancer Res 2011
167
23

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
539
23

Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Peter Bailey, Amber L Johns, David Miller, Katia Nones, Kelly Quek,[...]. Nature 2015
23

German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.
Ralph Schneider, Emily P Slater, Mercede Sina, Nils Habbe, Volker Fendrich, Elvira Matthäi, Peter Langer, Detlef K Bartsch. Fam Cancer 2011
98
22

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
22


A recurrent mutation in PALB2 in Finnish cancer families.
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko,[...]. Nature 2007
312
20

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
M Goggins, M Schutte, J Lu, C A Moskaluk, C L Weinstein, G M Petersen, C J Yeo, C E Jackson, H T Lynch, R H Hruban,[...]. Cancer Res 1996
490
20

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Nicholas J Roberts, Alexis L Norris, Gloria M Petersen, Melissa L Bondy, Randall Brand, Steven Gallinger, Robert C Kurtz, Sara H Olson, Anil K Rustgi, Ann G Schwartz,[...]. Cancer Discov 2016
170
20

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
262
19

PALB2 mutations in familial breast and pancreatic cancer.
Erin W Hofstatter, Susan M Domchek, Alexander Miron, Judy Garber, Molin Wang, Kathryn Componeschi, Leigh Boghossian, Penelope L Miron, Katherine L Nathanson, Nadine Tung. Fam Cancer 2011
68
27

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Marcia Irene Canto, Ralph H Hruban, Elliot K Fishman, Ihab R Kamel, Richard Schulick, Zhe Zhang, Mark Topazian, Naoki Takahashi, Joel Fletcher, Gloria Petersen,[...]. Gastroenterology 2012
389
18

PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu. Curr Biol 2009
330
18

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
211
18

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
139
18

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
Marcia Irene Canto, Michael Goggins, Ralph H Hruban, Gloria M Petersen, Francis M Giardiello, Charles Yeo, Elliott K Fishman, Kieran Brune, Jennifer Axilbund, Constance Griffin,[...]. Clin Gastroenterol Hepatol 2006
362
16

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Sarah Reid, Detlev Schindler, Helmut Hanenberg, Karen Barker, Sandra Hanks, Reinhard Kalb, Kornelia Neveling, Patrick Kelly, Sheila Seal, Marcel Freund,[...]. Nat Genet 2007
428
16

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Bella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert,[...]. J Clin Oncol 2015
998
16

Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.
Femme Harinck, Irma Kluijt, Saskia E van Mil, Quinten Waisfisz, Theo A M van Os, Cora M Aalfs, Anja Wagner, Maran Olderode-Berends, Rolf H Sijmons, Ernst J Kuipers,[...]. Eur J Hum Genet 2012
31
48

Importance of age of onset in pancreatic cancer kindreds.
Kieran A Brune, Bryan Lau, Emily Palmisano, Marcia Canto, Michael G Goggins, Ralph H Hruban, Alison P Klein. J Natl Cancer Inst 2010
114
15

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Robert C Grant, Iris Selander, Ashton A Connor, Shamini Selvarajah, Ayelet Borgida, Laurent Briollais, Gloria M Petersen, Jordan Lerner-Ellis, Spring Holter, Steven Gallinger. Gastroenterology 2015
170
15

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Hans Vasen, Isaura Ibrahim, Carmen Guillen Ponce, Emily P Slater, Elvira Matthäi, Alfredo Carrato, Julie Earl, Kristin Robbers, Anneke M van Mil, Thomas Potjer,[...]. J Clin Oncol 2016
157
15

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
Emily P Slater, Peter Langer, Volker Fendrich, Nils Habbe, Brunhilde Chaloupka, Elvira Matthäi, Mercedes Sina, Stephan A Hahn, Detlef K Bartsch. Fam Cancer 2010
33
42

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
Elizabeth C Verna, Caroline Hwang, Peter D Stevens, Heidrun Rotterdam, Stavros N Stavropoulos, Carolyn D Sy, Martin A Prince, Wendy K Chung, Robert L Fine, John A Chabot,[...]. Clin Cancer Res 2010
157
14

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
14

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.
F M Giardiello, G J Offerhaus, D H Lee, A J Krush, A C Tersmette, S V Booker, N C Kelley, S R Hamilton. Gut 1993
239
14

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
P Langer, P H Kann, V Fendrich, N Habbe, M Schneider, M Sina, E P Slater, J T Heverhagen, T M Gress, M Rothmund,[...]. Gut 2009
164
14

Familial pancreatic cancer--current knowledge.
Detlef K Bartsch, Thomas M Gress, Peter Langer. Nat Rev Gastroenterol Hepatol 2012
96
14

BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
Cristina R Ferrone, Douglas A Levine, Laura H Tang, Peter J Allen, William Jarnagin, Murray F Brennan, Kenneth Offit, Mark E Robson. J Clin Oncol 2009
137
14

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.
Maria C Villarroel, N V Rajeshkumar, Ignacio Garrido-Laguna, Ana De Jesus-Acosta, Siân Jones, Anirban Maitra, Ralph H Hruban, James R Eshleman, Alison Klein, Daniel Laheru,[...]. Mol Cancer Ther 2011
174
14

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.
J Iqbal, A Ragone, J Lubinski, H T Lynch, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen, S L Neuhausen,[...]. Br J Cancer 2012
148
14

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014
203
14

Clinical and genetic characteristics of hereditary pancreatitis in Europe.
Nathan Howes, Markus M Lerch, William Greenhalf, Deborah D Stocken, Ian Ellis, Peter Simon, Kaspar Truninger, Rudi Ammann, Giorgio Cavallini, Richard M Charnley,[...]. Clin Gastroenterol Hepatol 2004
371
14

Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Chunling Hu, Steven N Hart, William R Bamlet, Raymond M Moore, Kannabiran Nandakumar, Bruce W Eckloff, Yean K Lee, Gloria M Petersen, Robert R McWilliams, Fergus J Couch. Cancer Epidemiol Biomarkers Prev 2016
73
19

Germline mutations in Japanese familial pancreatic cancer patients.
Erina Takai, Shinichi Yachida, Kyoko Shimizu, Junji Furuse, Emi Kubo, Akihiro Ohmoto, Masami Suzuki, Ralph H Hruban, Takuji Okusaka, Chigusa Morizane,[...]. Oncotarget 2016
36
38


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.